Related Articles
Mediastinal and hilar sarcoid‑like reaction in a patient treated with dabrafenib and trametinib for metastatic melanoma: A case report and review of the literature
GLI inhibitor GANT61 kills melanoma cells and acts in synergy with obatoclax
Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma
Synergistic effects of vemurafenib and fingolimod (FTY720) in vemurafenib‑resistant melanoma cell lines
Growth arrest by activated BRAF and MEK inhibition in human anaplastic thyroid cancer cells